Please try another search
LONDON - AstraZeneca PLC (LSE:LON:AZN) has announced the appointment of two new Non-Executive Directors to its board. Rene Haas, CEO of Arm, and Birgit Conix, CFO of Sonova, will join the company...
WASHINGTON - AstraZeneca (NASDAQ:AZN)'s supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has been accepted and given Priority Review by the U.S. Food and Drug Administration...
LONDON - AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), the UK-based global biopharmaceutical company, has announced the appointment of Iskra Reic as its new Executive Vice President (EVP), International....
GuruFocus - Revenue: $1.7 million for Q3 2024.Research and Development Expenses: $18 million for Q3 2024, up from $11 million in the prior year period.Selling, General, and Administrative Expenses:...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review